While TNFAIP8L3 in the context of OVCA therapy appears to be associated with antitumor immunity, TNFAIP8 in other cancers exhibits oncogenic properties by inhibiting apoptosis and promoting tumor progression. This evidence concerns the gene TNFAIP8 and cancer.